GlassScriptPhysician profile
Frederick P Walters
NPI 1114952074
$7,040.24
in general payments reported to CMS, 2019-2025
45 companies · $1,278 in 2025
The $1,278 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $160 · 2021: $1,021 · 2022: $1,443 · 2023: $946 · 2024: $1,282 · 2025: $1,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,451 · Education: $35.06 · Entertainment: $20.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,450.86 |
| Education | $35.06 |
| Entertainment | $20.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $787.84 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $563.57 | 2019-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $484.76 | 2019-2025 | |
| Boston Scientific Corporation | $475.49 | 2019-2024 | Rezum Generator, Lithovue, Ams 700 Cxr Rte Kit |
| Antares Pharma, INC. | $354.18 | 2019-2022 | |
| Abbvie INC. | $348.79 | 2019-2024 | Botox, Lupron Depot |
| Myriad Genetic Laboratories, INC. | $344.54 | 2021-2025 | Prolaris |
| Verity Pharmaceuticals INC. | $297.61 | 2023-2025 | Trelstar |
| Sumitomo Pharma America, INC. | $295.56 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $279.03 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Endo Pharmaceuticals INC. | $248.17 | 2019-2024 | Xiaflex |
| Tolmar, INC. | $206.05 | 2023-2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $190.33 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $159.06 | 2024-2025 | Xiaflex |
| Myovant Sciences INC. | $154.56 | 2021-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.